Beckman Coulter 386358 Access OV Monitor Calibrators
$165.00
Brand: Beckman CoulterTest Name: CA 125
Article Number: 386358
- Description
Description
Beckman Coulter 386358 Access OV Monitor calibrator (CA 125 Test) Specifications:
- Manufacturer: Beckman Coulter 386358
- Country of Origin: United States
- Application: OV Monitor Calibrator
- Test Type: CA 125 Test
- For Use With: For Access, Access 2, UniCel DxI 600 and UniCel DxI 800 Systems
- Volume: 6 x 2.5 L
- Beckman Coulter 386358 Data Sheet
- Related Products:
Beckman Coulter 386358 Access OV Monitor calibrator (CA 125 Test): INTENDED USE
The Access OV Monitor Calibrators are intended to calibrate the Access OV Monitor assay for the quantitative determination of CA 125 antigen levels in human serum and plasma using the Access Immunoassay Systems.
Beckman Coulter 386358 Access OV Monitor calibrator (CA 125 Test): SUMMARY AND EXPLANATION
Quantitative assay calibration is the process by which samples with known analyte concentrations (i.e., assay calibrators) are tested like patient samples to measure the response. The mathematical relationship between the measured responses and the known analyte concentrations establishes the calibration curve. This mathematical relationship, or calibration curve, is used to convert RLU (Relative Light Unit) measurements of patient samples to specific quantitative analyte concentrations.
CA 125 Test Overview
A CA 125 test measures the amount of the protein CA 125 (cancer antigen 125) in the blood.
This test may be used to monitor certain cancers during and after treatment. In some situations, the test may be used to look for early signs of ovarian cancer in people with a very high risk of the disease.
A CA 125 test isn’t accurate enough to use for ovarian cancer screening in general because many conditions can increase the level of this protein.
Conditions that can cause an increase in CA 125 include many that aren’t cancerous, such as menstruation and uterine fibroids. Certain cancers may also cause an increased level of CA 125, including ovarian, endometrial, peritoneal and fallopian tube cancers.
Why CA 125 Test is required?
Your health care provider may recommend a CA 125 test for several reasons:
- To monitor cancer treatment. If you have ovarian, endometrial, peritoneal or fallopian tube cancer, your provider may recommend a CA 125 test on a regular basis to monitor your condition and treatment.But such monitoring hasn’t been shown to improve the outcome for those with ovarian cancer, and it might lead to additional and unnecessary rounds of chemotherapy or other treatments.
- To screen for ovarian cancer if you’re at high risk. If you have a strong family history of ovarian cancer or you have an inherited gene that increases the risk of ovarian cancer, your provider may recommend a CA 125 test as one way to screen for this cancer.Some providers may recommend CA 125 testing combined with transvaginal ultrasound every 6 to 12 months for those at very high risk.However, some people with ovarian cancer may not have an increased CA 125 level. And no evidence shows that this screening decreases the chance of dying of ovarian cancer. An elevated level of CA 125 could prompt your provider to put you through unnecessary and possibly harmful tests.
- To check for cancer recurrence. Rising CA 125 levels may indicate that ovarian cancer has come back after treatment. Regular monitoring of CA 125 has not been shown to improve outcomes for those with ovarian cancer and may lead to additional and unnecessary rounds of chemotherapy or other treatments.
